| Subject: | CMS Seeks Comments on Coverage of Erythropoiesis Stimulating Agents |
| Category: | Centers for Medicare and Medicaid Services (CMS)
|
| Published: | Thu, 22 Mar 2007 - 12:00 am |
| CMS is seeking public comment on its National Coverage Analysis (NCA) for the use of Erythropoiesis Stimulating Agents (ESA’s) for conditions other than end-stage renal disease (ESRD) due to the recent FDA warnings regarding the use of ESA’s.
On March 9, 2007 the FDA issued a public health advisory outlining new safety information, including revised product labeling about ESA’s, widely used drugs for the treatment of anemia. The drugs affected by the safety update are darbepoetin alfa... The full article is available to StayAlert subscribers. Click here for a free trial subscription. |
|
RESOURCES:
Customizable Documents and Tools:
External Links:
|
|
StayAlert! provides immediate online healthcare compliance validation to our healthcare users. When faced with dramatic reductions in healthcare dollars, StayAlert! focuses on those processes that can save the most time and money. By automating labor-intensive activities, StayAlert! almost instantly produces a positive impact on the healthcare user's bottom line. The policies alone included with the StayAlert! notices can save you $65,000 or more in labor costs each year. Organizations will realize dramatic cost savings through elimination of labor intensity, increased productivity with the benefit of ensuring regulatory compliance. StayAlert! is the service-oriented supplier of health care's compliance needs. StayAlert! is the only comprehensive clinical and regulatory service providing organizations in the healthcare arena with practical applications to meet complex mandated federal requirements. |
|
